SkyView Investment Advisors’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

SkyView Investment Advisors’s Portfolio OACC Stock Details OACC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.23M	Buy	+115,002	New	+$1.22M	0.96%	33

Other funds holding OACC

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

FBCM

Fort Baker Capital Management Larkspur, California $1.37B AUM 26.91% 1-Year Est. Return

DAM

Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return

ECP

Empyrean Capital Partners Los Angeles, California $3.03B AUM 47.81% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

BGGS

Boussard & Gavaudan Gestion SAS Paris, France $1.99B AUM

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

SkyView Investment Advisors's OACC Position: Q2 2026 in Review

SkyView Investment Advisors opened a new position in Oaktree Acquisition Corp III Life Sciences (OACC) in Q2 2026: 115,002 shares worth $1.23M. The stake represents 0.96% of the portfolio and ranks #33 among its holdings.

51 funds tracked by Wall St. Rank hold OACC as of Q2 2026.

SkyView Investment Advisors held 115,002 shares of Oaktree Acquisition Corp III Life Sciences worth $1.23M as of Q2 2026.
Oaktree Acquisition Corp III Life Sciences was a new SkyView Investment Advisors position in Q2 2026.
Oaktree Acquisition Corp III Life Sciences made up 0.96% of SkyView Investment Advisors's portfolio in Q2 2026, its #33 holding.
51 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q2 2026.

Based on SkyView Investment Advisors's 13F filing for Q2 2026, filed 15 Sep 2026.